IBD
Recent news mentioning IBD
- — How Okta, IBD Stock Of The Day, Is Targeting 'Nonhuman' Identity Opportunity
- — Two AI Names Bounce From Chip Sell-Off; Three More IBD 50 Stocks On Watch
- — Why Halozyme, An IBD 50 Stock, Just Hit A Record High In Bullish Volume
- — IBD 50 Stock Natera Zips Into Profit-Taking Zone On Its Blowout Quarter
- — Why This Top-Ranked IBD 50 Stock Just Tumbled On Its Earnings
- — HPE, IBD Stock Of The Day, Tests Buy Point As AI Drives Growth
- — This ETF, The IBD Stock Of The Day, Breaks Out As Cybersecurity Stocks Rebound
- — IBD Stock Of The Day: GE Aerospace Rises In Buy Zone After Earnings Letdown
- — Datadog, IBD Stock Of The Day, Rides AI Momentum Ahead Of Earnings Report
- — Palisade Bio Draws Bullish Call, Lead IBD Drug Advances Toward Phase 2
- — How Roche Unexpectedly Buoyed IBD Stock Of The Day TG Therapeutics
- — Stock Market Leaders Flourish Daily In IBD's Actionable New Highs Screen
Appears alongside
See IBD's full profile, network and analytical read on Beyond →